wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38816270-7A655509-8E77-4AC6-B910-A489859764C0
Q38816270-7A655509-8E77-4AC6-B910-A489859764C0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38816270-7A655509-8E77-4AC6-B910-A489859764C0
Central nervous system involvement in ALK-rearranged NSCLC: promising strategies to overcome crizotinib resistance.
P2860
Q38816270-7A655509-8E77-4AC6-B910-A489859764C0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38816270-7A655509-8E77-4AC6-B910-A489859764C0
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
1895d52775b13b46e66b810f9c708cb3ecbbe439
P2860
Alectinib induces a durable (>15 months) complete response in an ALK-positive non-small cell lung cancer patient who progressed on crizotinib with diffuse leptomeningeal carcinomatosis.